http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2034829-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fb82d307ace133fc0043edb3074b6f6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-12
filingDate 2007-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47f9051037c231479d98b209ba5b36c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f3b454c6ba06a4f0ea630d148173fd8
publicationDate 2009-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2034829-A1
titleOfInvention Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association
abstract The present invention relates to an association of active ingredients. More specifically: to an association of cyclobenzaprine and aceclofenac. Additionally, the present invention is also related to the use of aceclofenac and cyclobenzaprine, in association for the preparation of a medicine useful in the treatment of painful muscular diseases, as well as to a method of treatment of painful muscular diseases using an association of aceclofenac and cyclobenzaprine.
priorityDate 2006-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9947123-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002066691-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0009808-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229834474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229834476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68815085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68815087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128330127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128620599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453504489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247851220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22576

Total number of triples: 42.